FTC, Boehringer Wrangle Over Generics Settlement Docs
The Federal Trade Commission, on the hunt for documents relating to a patent settlement it is investigating between Boehringer Ingelheim Pharmaceuticals Inc. and Barr Pharmaceuticals Inc. that may have unlawfully delayed...To view the full article, register now.
Already a subscriber? Click here to view full article